Heritage Trust Co Purchases 546 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Heritage Trust Co has increased its holdings in Intuitive Surgical, Inc. by 31.1%, acquiring 546 additional shares in the 1st quarter, bringing its total shares to 2,303 valued at approximately $1.14 million.
• Intuitive Surgical reported strong earnings, with EPS of $2.19 for the quarter, surpassing analysts' expectations and showing a 21.4% increase in year-over-year revenue.
• Currently, analysts maintain a "Moderate Buy" consensus rating for Intuitive Surgical, with a target price of approximately $595.95, reflecting positive sentiment towards the company's growth potential.

Heritage Trust Co grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 31.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,303 shares of the medical equipment provider's stock after acquiring an additional 546 shares during the period. Heritage Trust Co's holdings in Intuitive Surgical were worth $1,141,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Castleark Management LLC increased its stake in shares of Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Arlington Trust Co LLC increased its stake in shares of Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after purchasing an additional 78 shares in the last quarter. Longbow Finance SA increased its stake in shares of Intuitive Surgical by 132.0% during the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock valued at $9,756,000 after purchasing an additional 11,209 shares in the last quarter. Finally, Ewing Morris & Co. Investment Partners Ltd. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $454,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $483.12 on Monday. The company's fifty day simple moving average is $524.01 and its 200-day simple moving average is $532.67. The stock has a market capitalization of $173.19 billion, a PE ratio of 67.38, a P/E/G ratio of 5.06 and a beta of 1.59. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the previous year, the company earned $1.78 EPS. Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on ISRG. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Piper Sandler reissued an "overweight" rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. BTIG Research raised their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price target for the company from $515.00 to $440.00 in a research report on Monday, June 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gary S. Guthart sold 7,893 shares of Intuitive Surgical stock in a transaction on Monday, July 28th. The shares were sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the transaction, the insider owned 13,187 shares in the company, valued at approximately $6,575,565.68. This trade represents a 37.44% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,903 shares of company stock worth $7,932,778. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.